Navigation Links
Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data

ngle therapies could be effectively treated to this goal with Exforge, regardless of previous treatment.
In patients with type 2 diabetes in the same study, Exforge helped an impressive five out of 10 achieve a more aggressive treatment goal of reducing blood pressure to 130/80 mmHg.
"Most patients will require two or more medications to achieve optimal sustained blood pressure control," said Dr. Joseph Izzo, the lead investigator from the Department of Medicine at the State University of New York in Buffalo. "These data show that using Exforge in a real-life setting can get patients who were previously uncontrolled to a healthy blood pressure goal."
Following Swiss and European Union approval in early 2007, Exforge is currently available in Germany, Switzerland and the UK and is planned to be launched in the rest of the EU in 2007/2008. The US Food and Drug Administration (FDA) granted tentative approval for Exforge in December 2006, and this medicine is expected to become available in the US later in 2007 following the expiration of market exclusivity for Norvasc®* (amlodipine).
"Exforge is a very exciting addition to our cardiovascular portfolio," said Dr. James Shannon, Global Head of Development at Novartis Pharma AG. "The fact that nearly 70% of people with high blood pressure still do not have this potentially fatal condition under control demonstrates the need for powerful and more effective therapies."
High blood pressure and its consequences is the world's No. 1 cause of death[5]. This condition, also called hypertension, is when the blood in the body moves through the blood vessels at a higher pressure than normal and causes damage to the arteries, kidneys, brain and ot
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
2. Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
(Date:8/29/2014)... ANDOVER, Mass. , Aug. ...  (NYSE: PHG ... at the  European Society of ... company is highlighting the full range of its cardiology solutions ... the care continuum from prevention and ...
(Date:8/28/2014)... Long, P.A.: , Do you, or did you, ... , Did you purchase your shares before September 10, 2013, ... , Did you lose money in your investment in Lannett ... rights? Rigrodsky & Long, P.A. , ... , announces that a complaint has been filed in the United ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces ... available in its catalogue: Needle-Free ... http://www.reportlinker.com/p02332847/Needle-Free-Delivery-Technology-and-Market-Forecast-2014-2024.html ... technological and commercial prospects What does the ... Visiongain,s brand new report shows you the ...
Breaking Medicine Technology:Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 2Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 3Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 4Philips Spotlights New Cardiology Solutions and Unveils Ultrasound Technology at European Society of Cardiology Congress 2014 5Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 2Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Lannett Company, Inc. 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 2Needle-Free Delivery: Technology and Market Forecast 2014-2024 3Needle-Free Delivery: Technology and Market Forecast 2014-2024 4Needle-Free Delivery: Technology and Market Forecast 2014-2024 5Needle-Free Delivery: Technology and Market Forecast 2014-2024 6Needle-Free Delivery: Technology and Market Forecast 2014-2024 7Needle-Free Delivery: Technology and Market Forecast 2014-2024 8Needle-Free Delivery: Technology and Market Forecast 2014-2024 9Needle-Free Delivery: Technology and Market Forecast 2014-2024 10Needle-Free Delivery: Technology and Market Forecast 2014-2024 11Needle-Free Delivery: Technology and Market Forecast 2014-2024 12Needle-Free Delivery: Technology and Market Forecast 2014-2024 13Needle-Free Delivery: Technology and Market Forecast 2014-2024 14Needle-Free Delivery: Technology and Market Forecast 2014-2024 15Needle-Free Delivery: Technology and Market Forecast 2014-2024 16Needle-Free Delivery: Technology and Market Forecast 2014-2024 17Needle-Free Delivery: Technology and Market Forecast 2014-2024 18
... Accuray Incorporated (Nasdaq: ... field of radiation oncology, today hosted a roundtable discussion ... is currently pending Congressional ratification. Offering the potential to ... the agreement, if ratified, promises important benefits to San ...
... (Nasdaq: AMLN ), Eli Lilly and Company (NYSE: ... ALKS ) today announced additional results from a phase 2 ... which showed substantial improvements in glycemic control, including reductions in ... findings will be presented in a late breaking poster session ...
Cached Medicine Technology:Accuray Hosts Korean Embassy's Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement 2Accuray Hosts Korean Embassy's Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement 3Accuray Hosts Korean Embassy's Minister for Economic Affairs at Event to Support the U.S.-Korea Free Trade Agreement 4Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 2Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 3Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 4Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 5Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 6Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 7Once-Monthly Exenatide Improved Glucose Control in Patients with Type 2 Diabetes: Phase 2 Study Results Presented at ADA 2011 8
(Date:8/29/2014)... (PRWEB) August 29, 2014 As reported by ... Addicts' Recovery , an Ohio municipal court drug has come ... addiction. Fred Moses, who serves as the presiding judge in ... law makers to offer addicts a medicated treatment option that ... utilizes the drug known as Vivitrol, which blocks receptors in ...
(Date:8/29/2014)... According to new research presented in a Science Daily article ... Drug Misuse Among Young Adults (8/16), peer pressure should ... it comes to prescription drug abuse. Researchers from Purdue University ... problem which influences misuse of prescription drugs is access to ... to have fun with other using friends. Evidently there is ...
(Date:8/29/2014)... Dallas, Texas (PRWEB) August 30, 2014 ... Glass microfiber Industry, 2009-2019 is a professional and ... microfiber industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, Production value, and market ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Healthpointe has ... will give patients the convenience of visiting with physicians ... doctors through telemedicine. , Healthpointe doctors are always available ... audio). If necessary, the doctor can even see the ... patient’s condition, he or she can prescribe medications that ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Healthpointe ... Chapman University Physical Therapy students via Clinical Rotations. ... University will be shadowing Healthpointe providers and specialists ... them to develop clinical experience and learn professional ... students will gain insight into several patient care ...
Breaking Medicine News(10 mins):Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2
... Rational Prescribing," a web-based lesson developed by faculty at ... Product of the Year" recently among products developed by ... The designation was made at the national meeting ... funds comprehensive programs to strengthen physicians, training in geriatrics. ...
... DALLAS and JACKSONVILLE, Fla., Jan. 11 Pollster Frank Luntz ... health care issue that resonates on both sides of the ... Christopher Fey, founder of U.S. Preventive Medicine®. , In the ... Doocy said, "Lawmakers will have to work out the Senate ...
... , , , PHILADELPHIA, Jan. 11 Global integrated ... in a state-of-the-art inventory management system - incorporating real ... and the Penn Customer Portal. This system makes Penn ... in the U.S. or Europe to provide customers with ...
... who have both diabetes and prostate cancer have significantly ... diabetes who undergo the same procedure, according to research ... Epidemiology, Biomarkers & Prevention . Many studies have ... of developing prostate cancer -- at least in white ...
... Mattress Warehouse will ... 9 a.m. to 5 p.m. The mattress retailer will be presenting mattresses from its Simmons ... (PRWEB) January ... Saturday and Sunday, January 16-17, 2010, 9 a.m. to 5 p.m. The mid-Atlantic mattress retailer ...
... The Executive Council of the International Association of Machinists ... health care reform legislation that is funded by taxing the ... IAM members exchanged substantial wage increases for the best possible ... bizarre turn of events, their insurance premiums will be subject ...
Cached Medicine News:Health News:Web-based curriculum in rational prescribing wins geriatrics Educational Product of the Year Award 2Health News:Republicans and Democrats Agree on The Prevention Plan(R); Ad Scores with Frank Luntz Audience 2Health News:Penn Pharma Invests In World-Class Inventory Management System 2Health News:Race, obesity affect outcomes among diabetics following prostatectomy 2Health News:Mattress Warehouse to Present at the NBC-4 Health & Fitness Expo in Washington, DC 2Health News:Machinists Union Leaders Vote to Oppose Health Benefits Tax 2
... VS1 is an easy to ... provides reliable, accurate, automated measurements ... designed to make your job ... bright, color-coded LED readings, proven ...
... (OLEH), an interactive electronic textbook, provides ... OLEH brings clinical decision support information ... right on the patient monitor screen ... and contributing to error reduction ...
... monitoring for flexible care settings., ... combine portability and measurement flexibility to ... of intermediate care environmentsat the patients ... heritage in patient monitoring, IntelliVue has ...
... The IntelliVue MP90 is designed to ... the highest acuity care environments. Built on ... IntelliVue MP90 with dual independent displays has ... measurements menu; built-in clinical support tools such ...
Medicine Products: